title: Anticipating and managing bleeding complications in patients with coronary stents who are receiving dual antiplatelet treatment.
authors.affiliation: Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford OX3 7LF, UK. nijbhala@doctors.org.uk
authors.forename: Neeraj
authors.initials: N
authors.lastname: Bhala
authors.forename: Jaspal S
authors.initials: JS
authors.lastname: Taggar
authors.forename: Praveen
authors.initials: P
authors.lastname: Rajasekhar
authors.forename: Amitava
authors.initials: A
authors.lastname: Banerjee
mesh_terms: D016913:Blood Component Transfusion; D002408:Catheters, Indwelling; D000077144:Clopidogrel; D003029:Coagulants / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D054855:Drug-Eluting Stents; D016099:Endoscopy, Gastrointestinal / Q000379:methods; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005544:Forecasting; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006470:Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D003029:Coagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine